- Home
- NLSP
as 07-26-2024 4:00pm EST
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
| Founded: | 2015 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 8.2M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 2.3M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.11 - $1.21 | Next Earning Date: | 08-06-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest NLS Pharmaceutics Ltd. News
NLSP Breaking Stock News: Dive into NLSP Ticker-Specific Updates for Smart Investing
MT Newswires
a month ago
NLS Pharmaceutics Announces Registered Direct Offering, Private Placement of Shares, Warrants
ACCESSWIRE
a month ago
NLS Pharmaceutics Announces Registered Direct Offering
MT Newswires
a month ago
Top Midday Gainers
MT Newswires
a month ago
NLS Pharmaceutics Reports Preclinical Data for Potential Parkinson's Disease Treatments; Shares Jump
ACCESSWIRE
a month ago
NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
ACCESSWIRE
a month ago
Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
ACCESSWIRE
2 months ago
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)
ACCESSWIRE
2 months ago
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
Compare NLSP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NLSP NLS Pharmaceutics Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.